Species differences of macrophage very low-density-lipoprotein (VLDL) receptor protein expression

Biochemical and Biophysical Research Communications

Volumn 407, Issue 4, 2011, Pages 656-662

  Takahashi, Sadao ^a   Ito, Takashi ^b   Zenimaru, Yasuo ^a   Suzuki, Jinya ^a   Miyamori, Isamu ^a   Takahashi, Masao ^c   Takahashi, Masafumi ^d   Ishida, Takafumi ^e   Ishida, Tatsuro ^b   Hirata, Ken ichi ^b   Yamamoto, Tokuo T ^f   Iwasaki, Tadao ^g   Hattori, Hiroaki ^g   Shiomi, Masashi ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Hiratsuka Kyosai Hospital   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f TOHOKU UNIVERSITY   (Japan)

^g BML   (Japan)

Author keywords

Atherosclerosis; Foam cell formation; LDL receptor; Macrophages; Species differences; VLDL receptor

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SPECIES DIFFERENCE; WATANABE HERITABLE HYPERLIPIDEMIC RABBIT;

ANIMALS; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; RABBITS; RECEPTORS, LDL; SPECIES SPECIFICITY;

ANIMALIA; MUS; ORYCTOLAGUS CUNICULUS;

EID: 79954993713     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.069     Document Type: Article

References (30)

1. Grundy S.M., Cleeman J.I., Merz C.N., et al. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler. Thromb. Vac. Biol. 2004, 24:1329-1330.
2. Ginsberg H.N. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 2002, 106:2137-2142.
3. Glass C.K., Witztum J.L. Atherosclerosis: the road ahead. Cell 2001, 104:503-516.
4. Li A.C., Glass C.K. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 2002, 8:1235-1242.
5. Kosaka S., Takahashi S., Masamura K., et al. Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages. Circulation 2001, 103:1142-1147.
6. Fujioka Y., Cooper A.D., Fong L.G. Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages. J. Lipid Res. 1998, 39:2339-2349.
7. Perrey S., Ishibashi S., Kitamine T., et al. The LDL receptor is the major pathway for beta-VLDL uptake by mouse peritoneal macrophages. Atherosclerosis 2001, 154:51-60.
8. Takahashi S., Kawarabayasi Y., Nakai T., et al. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA 1992, 89:9252-9256.
9. Sakai J., Hoshino A., Takahashi S., et al. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J. Biol. Chem. 1994, 269:2173-2182.
10. Takahashi S., Suzuki J., Kohno M., et al. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J. Biol. Chem. 1995, 270:15747-15754.
11. Takahashi S., Sakai J., Fujino T., et al. The very low density lipoprotein (VLDL) receptor - a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues. Mol. Cell Biochem. 2003, 248:121-127.
12. Takahashi S., Sakai J., Fujino T., et al. The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J. Atheroscler. Thromb. 2004, 11:200-208.
13. Multhaupt H.A., Gafvels M.E., Kariko K., et al. Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry. Am. J. Pathol. 1996, 148:1985-1997.
14. Argraves K.M., Kozarsky K.F., Fallon J.T., et al. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J. Clin. Invest. 1997, 100:2170-2181.
15. Nakazato K., Ishibashi T., Shindo J., et al. Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions. Am. J. Pathol. 1996, 149:1831-1838.
16. Hiltunen T.P., Luoma J.S., Nikkari T., et al. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 1998, 97:1079-1086.
17. Frykman P.K., Brown M.S., Yamamoto T., et al. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 1995, 92:8453-8457.
18. Shiomi M., Ito T., Yamada S., et al. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler. Thromb. Vac. Biol. 2003, 23:1239-1244.
19. Zhang S.H., Reddick R.L., Piedrahita J.A., et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
20. Ishibashi S., Goldstein J.L., Brown M.S., et al. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 1994, 93:1885-1893.
21. Yamamoto T., Davis C.G., Brown M.S., et al. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 1984, 39:27-38.
22. Kim D.H., Iijima H., Goto K., et al. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem. 1996, 271:8373-8380.
23. Kraemer F.B., Chen Y.D., Lopez R.D., et al. Characterization of the binding site on thioglycolate-stimulated mouse peritoneal macrophages that mediates the uptake of very low density lipoproteins. J. Biol. Chem. 1983, 258:12190-12197.
24. Zenimaru Y., Takahashi S., Takahashi M., et al. Glucose deprivation accelerates VLDL receptor-mediated TG-rich lipoprotein uptake by AMPK activation in skeletal muscle cells. Biochem. Biophys. Res. Commun. 2008, 368:716-722.
25. Shiomi M., Ito T., Tsukada T., et al. Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ. An immunohistochemical study. Arterioscler. Thromb. 1994, 14:931-937.
26. Gafvels M.E., Paavola L.G., Boyd C.O., et al. Cloning of a complementary deoxyribonucleic acid encoding the murine homolog of the very low density lipoprotein/apolipoprotein-E receptor: expression pattern and assignment of the gene to mouse chromosome 19. Endocrinology 1994, 135:387-394.
27. Oka K., Ishimura-Oka K., Chu M.J., et al. Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor. Eur. J. Biochem. 1994, 224:975-982.
28. Tacken P.J., Delsing D.J., Gijbels M.J., et al. VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area. Atherosclerosis 2002, 162:103-110.
29. Eck M.V., Oost J., Goudriaan J.R., et al. Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. Atherosclerosis 2005, 183:230-237.
30. Rapp J.H., Lespine A., Hamilton R.L., et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler. Thromb. 1994, 14:1767-1774.